BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15658562)

  • 1. Keratomycosis in six horses in the United Kingdom.
    Sansom J; Featherstone H; Barnett KC
    Vet Rec; 2005 Jan; 156(1):13-7. PubMed ID: 15658562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of itraconazole-dimethyl sulfoxide ointment for treatment of keratomycosis in nine horses.
    Ball MA; Rebhun WC; Gaarder JE; Patten V
    J Am Vet Med Assoc; 1997 Jul; 211(2):199-203. PubMed ID: 9227751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fungal species cultured on outcome in horses with fungal keratitis.
    Sherman AB; Clode AB; Gilger BC
    Vet Ophthalmol; 2017 Mar; 20(2):140-146. PubMed ID: 27061354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine keratomycosis in Japan.
    Wada S; Hobo S; Ode H; Niwa H; Moriyama H
    Vet Ophthalmol; 2013 Jan; 16(1):1-9. PubMed ID: 22372681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine subepithelial keratomycosis.
    Brooks DE; Plummer CE; Mangan BG; Ben-Shlomo G
    Vet Ophthalmol; 2013 Mar; 16(2):93-6. PubMed ID: 22583748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Therapy in Equine Ocular Mycotic Infections.
    Ledbetter EC
    Vet Clin North Am Equine Pract; 2017 Dec; 33(3):583-605. PubMed ID: 28958862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
    Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
    J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratomycosis in a pet rabbit (Oryctolagus cuniculus) treated with topical 1% terbinafine ointment.
    Bourguet A; Guyonnet A; Donzel E; Guillot J; Pignon C; Chahory S
    Vet Ophthalmol; 2016 Nov; 19(6):504-509. PubMed ID: 26632085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine keratomycosis in Switzerland: a retrospective evaluation of 35 horses (January 2000-August 2011).
    Voelter-Ratson K; Pot SA; Florin M; Spiess BM
    Equine Vet J; 2013 Sep; 45(5):608-12. PubMed ID: 23489138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo confocal microscopy of equine fungal keratitis.
    Ledbetter EC; Irby NL; Kim SG
    Vet Ophthalmol; 2011 Jan; 14(1):1-9. PubMed ID: 21199274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine keratomycoses in California from 1987 to 2010 (47 cases).
    Reed Z; Thomasy SM; Good KL; Maggs DJ; Magdesian KG; Pusterla N; Hollingsworth SR
    Equine Vet J; 2013 May; 45(3):361-6. PubMed ID: 22943420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic ophthalmology.
    Sandmeyer LS; Bauer BS; Robinson K; Grahn BH
    Can Vet J; 2014 Mar; 55(3):281-3. PubMed ID: 24587514
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution.
    Labelle AL; Hamor RE; Barger AM; Maddox CW; Breaux CB
    Vet Ophthalmol; 2009; 12(1):48-52. PubMed ID: 19152598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratomycosis in a Percheron cross horse caused by Cladorrhinum bulbillosum.
    Chopin JB; Sigler L; Connole MD; O'Boyle DA; Mackay B; Goldstein L
    J Med Vet Mycol; 1997; 35(1):53-5. PubMed ID: 9061586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo confocal microscopy characteristics of equine epithelial and subepithelial nonulcerative keratomycosis.
    Ledbetter EC; Irby NL; Teixeira LBC
    Vet Ophthalmol; 2019 Mar; 22(2):168-176. PubMed ID: 29722121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
    Tamura N; Okano A; Kuroda T; Niwa H; Kusano K; Matsuda Y; Fukuda K; Mita H; Nagata S
    Vet Ophthalmol; 2020 Jul; 23(4):640-647. PubMed ID: 32383526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987-1996).
    Andrew SE; Brooks DE; Smith PJ; Gelatt KN; Chmielewski NT; Whittaker CJ
    Equine Vet J; 1998 Mar; 30(2):109-16. PubMed ID: 9535066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratomycosis in a dog treated with topical 1% voriconazole solution.
    Grundon RA; O'Reilly A; Muhlnickel C; Hardman C; Stanley RG
    Vet Ophthalmol; 2010 Sep; 13(5):331-5. PubMed ID: 20840112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.